At close: December 13 at 4:00:02 PM EST
After hours: December 13 at 4:20:00 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Robert M. Hershberg M.D., Ph.D. | Co-Founder, President, CEO & Chairman of the Board | 1.04M | -- | 1962 |
| Dr. Aditya Kohli Ph.D. | Co-Founder, Chief Business Officer & Director | 765.87k | -- | 1988 |
| Ms. Astrid Borkowski M.D., Ph.D. | Chief Medical Officer | 854.56k | -- | 1970 |
| Mr. Shane A. Maltbie | CFO & Treasurer | -- | -- | 1982 |
| Mr. Sean McLoughlin | Chief Operating Officer | -- | -- | 1972 |
| Dr. Anju Chatterji Ph.D. | Chief Technology Officer | -- | -- | -- |
| Mr. Paul S. Bavier J.D. | General Counsel, Secretary & Chief Administrative Officer | -- | -- | 1972 |
| Mr. Ozzie Berger | Senior Vice President of Regulatory Affairs | -- | -- | -- |
HilleVax, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 90
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
Corporate Governance
HilleVax, Inc.’s ISS Governance QualityScore as of December 1, 2024 is 9. The pillar scores are Audit: 3; Board: 10; Shareholder Rights: 8; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 7, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
Related Tickers
IKNA Ikena Oncology, Inc.
1.6500
-0.60%
ACHL Achilles Therapeutics plc
0.9899
+0.34%
NXTC NextCure, Inc.
1.0800
-0.92%
ANTX AN2 Therapeutics, Inc.
1.4300
-3.38%
ASMB Assembly Biosciences, Inc.
15.38
+0.20%
KZR Kezar Life Sciences, Inc.
6.75
-0.44%
IPSC Century Therapeutics, Inc.
1.2200
-2.40%
KRON Kronos Bio, Inc.
0.9799
-2.01%
AADI Aadi Bioscience, Inc.
2.4100
0.00%
EPIX ESSA Pharma Inc.
1.6400
0.00%